share_log

BioNTech | 6-K: BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda

Dec 18, 2023 16:22
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more